Apr 28, 2009 - Genta Incorporated announced today that the European Patent Office intends to grant two key patents related to the Company's intellectual property position on Genasense (oblimersen sodium) Injection. The Company has proceeded with grant formalities and validation of the patents.
the details can be read here.
No comments:
Post a Comment